Can a new drug stop Ketamine-Induced psychosis?
NCT ID NCT01892189
First seen May 13, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This study looked at whether a single dose of TAK-063 could prevent brain activity changes and psychotic-like symptoms caused by ketamine in 27 healthy adult men. Participants received TAK-063, a placebo, or ketamine in different sessions, and brain scans measured the drug's effects. The goal was to understand how TAK-063 works in the brain, not to treat a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KETAMINE-INDUCED BRAIN ACTIVITY CHANGES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Brain Institute, University of Utah
Salt Lake City, Utah, 84108, United States
Conditions
Explore the condition pages connected to this study.